Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas Patients underwent protocol high-resolution pelvic MRI.

Hypertension (HT) is the one of the most common causes of myocardial dysfunction. Although in the majority of hypertensive patients in stage 1 or 2 of the disease, global left ventricular (LV) ...

Differential expression in potential therapeutic target protein by treatment in small cell lung cancer with and without transformation. Dietary pattern and the corresponding gut microbiome in response ...

FREMONT, Calif.--(BUSINESS WIRE)--Ceterix ® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced the issuance of U.S. Patent No.